NASDAQ:LOAC

Longevity Acquisition Stock Forecast, Price & News

$10.95

-0.38 (-3.35 %)

(As of 01/27/2021 12:00 AM ET)

Add

Compare

Today's Range

$10.63

Now: $10.95▼

$11.43

50-Day Range

$10.73

MA: $12.03▼

$13.80

52-Week Range

$10.24

Now: $10.95▼

$19.25

Volume109,666 shs

Average Volume126,043 shs

Market Capitalization$28.75 million

P/E RatioN/A

Dividend YieldN/A

Beta-0.01

Longevity Acquisition Corporation does not have significant operations. The company focuses on acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing of assets, entering into contractual arrangements, or other business combination with one or more businesses. Longevity Acquisition Corporation was founded in 2018 and is based in Shanghai, the People's Republic of China.

Overall MarketRank^™

0.33 out of 5 stars

Unclassified Sector

69th out of 247 stocks

Holding & Other Investment Offices Industry

68th out of 204 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Longevity Acquisition.

0.0 Community Rank

Outperform Votes
Longevity Acquisition has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Longevity Acquisition has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Longevity Acquisition and other stocks. Vote “Outperform” if you believe LOAC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LOAC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Longevity Acquisition does not currently pay a dividend.
Dividend Growth
Longevity Acquisition does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Longevity Acquisition insiders have not sold or bought any company stock.
Percentage Held by Insiders
47.60% of the stock of Longevity Acquisition is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
51.38% of the stock of Longevity Acquisition is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Longevity Acquisition is -29.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Longevity Acquisition has a P/B Ratio of 11.90. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Holding & other investment offices

Sub-IndustryN/A

SectorUnclassified

Current SymbolNASDAQ:LOAC

Previous Symbol

CUSIPN/A

CIKN/A

WebN/A

Phone86 21 6083 2028

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity Ratio0.36

Current Ratio0.10

Quick Ratio0.10

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book Value$0.92 per share

Price / Book11.90

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-290,000.00

Net MarginsN/A

Return on Equity-10.12%

Return on Assets-1.43%

Miscellaneous

Outstanding Shares2,626,000

Market Cap$28.75 million

Next Earnings Date4/29/2021 (Estimated)

OptionableNot Optionable

$10.95

-0.38 (-3.35 %)

(As of 01/27/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive LOAC News and Ratings via Email

Sign-up to receive the latest news and ratings for LOAC and its competitors with MarketBeat's FREE daily newsletter.

Longevity Acquisition (NASDAQ:LOAC) Frequently Asked Questions

What stocks does MarketBeat like better than Longevity Acquisition?

Wall Street analysts have given Longevity Acquisition a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Longevity Acquisition wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Longevity Acquisition's next earnings date?

Longevity Acquisition is scheduled to release its next quarterly earnings announcement on Thursday, April 29th 2021.
View our earnings forecast for Longevity Acquisition.

Who are some of Longevity Acquisition's key competitors?

Some companies that are related to Longevity Acquisition include Chardan Healthcare Acquisition 2 (CHAQ), AgroFresh Solutions (AGFS), LIV Capital Acquisition (LIVK), LifeSci Acquisition II (LSAQ), Big Rock Partners Acquisition (BRPA), Petra Acquisition (PAIC), 5:01 Acquisition (FVAM), Leisure Acquisition (LACQ), Sandbridge Acquisition (SBG), ONE (AONE), AGBA Acquisition (AGBA), Alberton Acquisition (ALAC), Software Acquisition Group Inc. II (SAII), NewHold Investment (NHIC) and Andina Acquisition Corp. III (ANDA).
View all of LOAC's competitors.

Who are Longevity Acquisition's key executives?

Longevity Acquisition's management team includes the following people:

Mr. Matthew Chen, Chairman & CFO (Age 49)
Mr. Alex Lyamport, CEO & Director (Age 50)

What is Longevity Acquisition's stock symbol?

Longevity Acquisition trades on the NASDAQ under the ticker symbol "LOAC."

How do I buy shares of Longevity Acquisition?

Shares of LOAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Longevity Acquisition's stock price today?

One share of LOAC stock can currently be purchased for approximately $10.95.

How big of a company is Longevity Acquisition?

Longevity Acquisition has a market capitalization of $28.75 million.

How can I contact Longevity Acquisition?

Longevity Acquisition's mailing address is YONGDA INTERNATIONAL TOWER NO. 2277 LONGEVITY ROAD PUDONG DISTRICT, SHANGHAI F4, 20000. The company can be reached via phone at 86 21 6083 2028.

This page was last updated on 1/28/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here